16
Participants
Start Date
October 2, 2007
Primary Completion Date
December 1, 2007
Study Completion Date
GW685698X & GW642444M
study drug
GSK Investigational Site, Randwick, Sydney
Lead Sponsor
GlaxoSmithKline
INDUSTRY